Postdoctoral Fellows and Instructors
Alexandre Gaspar-Maia, PhD
Alex is now here:
Assistant Professor | Laboratory of Functional Epigenomics
200 First Street SW
Rochester MN 55905
Maia.Alexandre@mayo.edu | (507) 293-2464
Chiara Vardabasso, PhD
Chiara is now here:
Alexandria Center for Life Science, East Tower
430East 29th Street Suite 1435E
New York, NY 10016
Thomas Strub, PhD
Thomas is now here:
INSERM U1065 equipe 1
Centre Méditerranéen de Médecine Moléculaire Batiment Archimed
151 route Saint-Antoine de Ginestière
06204 Nice cedex 3
Tel: +33 (0) 4 89 06 43 33
April Cook, PhD
April is now here:
Multiple Myeloma Research Foundation (MMRF)
383 Main Ave 5th Floor
Norwalk CT 06851
Flávia Ghiraldini, PhD
Flávia is now here:
Protara Therapeutics, Inc.
345 Park Avenue South
New York, NY 10010
School of Medicine Students
Joanna’s work focused on elucidating the H2A.Z-mediated regulation and pathogenesis of melanoma. H2A.Z is a histone variant with many interactors, including histone chaperone complexes and transcriptional regulators, with translational potential in melanoma pharmacotherapeutic development. She used loss-of-function screens and co-immunoprecipitation studies to establish the functional roles of these H2A.Z interactors in melanoma cells.
Chi-Yeh (Jay) Chung, PhD
Jay performed postdoctoral studies in Geoffrey Wahl’s laboratory at the Salk Institute where he studied mammary stem cell state regulation using bioinformatic and epigenetic approaches. Jay is now a Principal Scientist and Team Leader of Cancer Epigenetics group at Pfizer in San Diego.
David Valle-Garcia, PhD
David performed a postdoctoral fellowship in Yang Shi’s lab at Harvard Medical School where he studied mRNA modifications. He is now a Researcher at the Institute of Biotechnology at National Autonomous University of Mexico.
Zulekha Qadeer, PhD
Zulekha is a postdoctoral scholar in the William A. Weiss Laboratory at the University of California San Francisco. Zulekha is investigating the mechanisms of known driving events to promote medulloblastoma utilizing a unique humanized model based on differentiation and transformation of human induced pluripotent stem cells.
Zulekha was supported by: Department of Defense Peer Reviewed Cancer Research Program Horizon Award (2016-2017)
Saul Carcamo, PhD
During his PhD studies in the lab, Saul gained a passion for bioinformatic analyses focused on the epigenome. He is now a Bioinformatician at the Bioinformatics for Next Generation Sequencing (BiNGS) core of the Tisch Cancer Institute at Mount Sinai: https://bings.mssm.edu/